SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: EX-10.4
Date Filed: 2026-03-18
Accession Number: 0001493152-26-010642
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226010642/ex10-4.htm

Chunk 7 of 8
Word Count: 207
Character Count: 1239

Document Content:

be null and void and of no force or effect on either the Company or the undersigned and the undersigned will not be entitled to any of the payments or benefits which are expressly conditioned upon the execution and non-revocation of this Release. Any revocation must be in writing and sent to [ name ], via electronic mail at [ email address ], on or before [5:00 p.m. Eastern time] on the seventh day after this Release is executed by the undersigned. Acknowledgement. The undersigned acknowledges that different or additional facts may be discovered in addition to what is now known or believed to be true by the undersigned with respect to the matters released in this Release, and the undersigned agrees that this Release shall be and remain in effect in all respects as a complete and final release of the matters released, notwithstanding any different or additional facts.

Governing Law. This Release is deemed made and entered into in the State of Delaware, and in all respects shall be interpreted,
enforced and governed under the internal laws of the State of Delaware, to the extent not preempted by federal law.

WITNESS WHEREOF, the undersigned has executed this Release this ____ day of ____________________.

David Richmond